Switch theme
Sign up to access all valuation multiples
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
2003
1.1K+
Last FY Revenue $20.7M
Last FY EBITDA $3.2M
$57.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Chandan Healthcare achieved revenue of $20.7M and an EBITDA of $3.2M.
Chandan Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chandan Healthcare valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $20.7M | XXX | XXX | XXX |
| Gross Profit | XXX | $11.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 54% | XXX | XXX | XXX |
| EBITDA | XXX | $3.2M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 15% | XXX | XXX | XXX |
| EBIT | XXX | $2.7M | XXX | XXX | XXX |
| EBIT Margin | XXX | 13% | XXX | XXX | XXX |
| Net Profit | XXX | $1.9M | XXX | XXX | XXX |
| Net Margin | XXX | 9% | XXX | XXX | XXX |
| Net Debt | XXX | $4.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Chandan Healthcare's stock price is INR 185 (or $2).
Chandan Healthcare has current market cap of INR 4.5B (or $53.0M), and EV of INR 4.9B (or $57.8M).
See Chandan Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $57.8M | $53.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Chandan Healthcare has market cap of $53.0M and EV of $57.8M.
Chandan Healthcare's trades at 2.8x EV/Revenue multiple, and 18.1x EV/EBITDA.
Equity research analysts estimate Chandan Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chandan Healthcare's P/E ratio is not available.
See valuation multiples for Chandan Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $53.0M | XXX | $53.0M | XXX | XXX | XXX |
| EV (current) | $57.8M | XXX | $57.8M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 18.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 21.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 27.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -28.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChandan Healthcare's revenue per employee in the last FY averaged $19K, while opex per employee averaged $8K for the same period.
Chandan Healthcare's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chandan Healthcare's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Chandan Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $19K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chandan Healthcare acquired XXX companies to date.
Last acquisition by Chandan Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Chandan Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Chandan Healthcare founded? | Chandan Healthcare was founded in 2003. |
| Where is Chandan Healthcare headquartered? | Chandan Healthcare is headquartered in India. |
| How many employees does Chandan Healthcare have? | As of today, Chandan Healthcare has 1.1K+ employees. |
| Is Chandan Healthcare publicy listed? | Yes, Chandan Healthcare is a public company listed on NSE. |
| What is the stock symbol of Chandan Healthcare? | Chandan Healthcare trades under CHANDAN ticker. |
| When did Chandan Healthcare go public? | Chandan Healthcare went public in 2025. |
| Who are competitors of Chandan Healthcare? | Similar companies to Chandan Healthcare include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Chandan Healthcare? | Chandan Healthcare's current market cap is $53.0M |
| Is Chandan Healthcare profitable? | Yes, Chandan Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
